Gilles has 35 years of experience in the pharmaceutical and biotechnology sectors. He created and developed OPi, Pharmaceuticals for Rare Diseases and has taken more than ten products through clinical trials.
Julien is a graduate of EM LYON Business School and IAE Lyon management school. He is the funder and the Chief Executive Officer of Mathym since 2013, a nanotechnology company acquired in 2019 by Baikowski SA, of which he is also the Business Development Director.
Jeremy is a pharmacist and oncologist, who specialises in immuno-oncology. He joined initiative OCTALFA and Orega Biotech in 2010 and Orphelia Pharma in 2015. He is Chief Executive Officer of OREGA Biotech.
Charlotte joined initiative OCTALFA in October 2016 as an executive assistant. Charlotte is also responsible for the administrative management of the Foundation’s projects, for which she is also administrator representing the company’s employees.
Thuy Linh is our Director for Legal, Administrative and Finance activities. She joined initiative Octalfa in December 2018.